Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Harry Cassin Managing Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor

FCPA Blog Daily News

Entries in Optimer Pharmaceuticals (2)


Cubist discloses DOJ, SEC investigations of Optimer payments

Cubist Pharmaceuticals Inc. said Monday that a global biopharmaceutical company it bought in 2013 may have violated the FCPA.

Click to read more ...


At Optimer Pharmaceuticals, FCPA and conflict problems topple top management and general counsel 

San Diego-based Optimer Pharmaceuticals said this week that its CEO and general counsel resigned last month at the request of independent board members after a year-long internal investigation uncovered potential compliance problems.

Click to read more ...